Statements (27)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:etorphine
|
| gptkbp:alternativeName |
gptkb:etorphine
|
| gptkbp:antidote |
gptkb:diprenorphine
|
| gptkbp:CASNumber |
14521-96-1
|
| gptkbp:category |
gptkb:veterinary_medicine
analgesic opioid |
| gptkbp:chemicalFormula |
C25H33NO4
|
| gptkbp:controlledSubstanceSchedule |
yes
|
| gptkbp:discoveredBy |
Macleod and colleagues
|
| gptkbp:firstSynthesized |
1960s
|
| https://www.w3.org/2000/01/rdf-schema#label |
M-99
|
| gptkbp:legalStatus |
gptkb:Schedule_I_(US)
|
| gptkbp:marketedAs |
Novartis (formerly ICI)
|
| gptkbp:molecularWeight |
395.54 g/mol
|
| gptkbp:notForHumanUse |
true
|
| gptkbp:potencyComparedToMorphine |
1000-3000 times more potent
|
| gptkbp:PubChem_CID |
5360515
|
| gptkbp:routeOfAdministration |
injection
|
| gptkbp:sideEffect |
nausea
respiratory depression bradycardia |
| gptkbp:UNII |
5U8D347KDG
|
| gptkbp:usedBy |
veterinarians
|
| gptkbp:usedFor |
immobilization of large animals
|
| gptkbp:bfsParent |
gptkb:M-43
|
| gptkbp:bfsLayer |
7
|